400 related articles for article (PubMed ID: 17254746)
1. Activity, toxicity and analysis of resistance of essential oil from Chenopodium ambrosioides after intraperitoneal, oral and intralesional administration in BALB/c mice infected with Leishmania amazonensis: a preliminary study.
Monzote L; Montalvo AM; Scull R; Miranda M; Abreu J
Biomed Pharmacother; 2007; 61(2-3):148-53. PubMed ID: 17254746
[TBL] [Abstract][Full Text] [Related]
2. Effect of oral treatment with the essential oil from Chenopodium ambrosioides against cutaneous leishmaniasis in BALB/c mice, caused by Leishmania amazonensis.
Monzote L; García M; Montalvo AM; Linares R; Scull R
Forsch Komplementmed; 2009 Oct; 16(5):334-8. PubMed ID: 19887812
[TBL] [Abstract][Full Text] [Related]
3. Activity of the essential oil from Chenopodium ambrosioides grown in Cuba against Leishmania amazonensis.
Monzote L; Montalvo AM; Almanonni S; Scull R; Miranda M; Abreu J
Chemotherapy; 2006; 52(3):130-6. PubMed ID: 16636536
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of the intralesional treatment with Chenopodium ambrosioides in the murine infection by Leishmania amazonensis.
Patrício FJ; Costa GC; Pereira PV; Aragão-Filho WC; Sousa SM; Frazão JB; Pereira WS; Maciel MC; Silva LA; Amaral FM; Rebêlo JM; Guerra RN; Ribeiro MN; Nascimento FR
J Ethnopharmacol; 2008 Jan; 115(2):313-9. PubMed ID: 18035510
[TBL] [Abstract][Full Text] [Related]
5. Antileishmanial activity of essential oil from Chenopodium ambrosioides and its main components against experimental cutaneous leishmaniasis in BALB/c mice.
Monzote L; Pastor J; Scull R; Gille L
Phytomedicine; 2014; 21(8-9):1048-52. PubMed ID: 24768411
[TBL] [Abstract][Full Text] [Related]
6. Comparative chemical, cytotoxicity and antileishmanial properties of essential oils from Chenopodium ambrosioides.
Monzote L; Nance MR; García M; Scull R; Setzer WN
Nat Prod Commun; 2011 Feb; 6(2):281-6. PubMed ID: 21425695
[TBL] [Abstract][Full Text] [Related]
7. Combined effect of the essential oil from Chenopodium ambrosioides and antileishmanial drugs on promastigotes of Leishmania amazonensis.
Monzote L; Montalvo AM; Scull R; Miranda M; Abreu J
Rev Inst Med Trop Sao Paulo; 2007; 49(4):257-60. PubMed ID: 17823757
[TBL] [Abstract][Full Text] [Related]
8. In vitro activity of an essential oil against Leishmania donovani.
Monzote L; García M; Montalvo AM; Scull R; Miranda M; Abreu J
Phytother Res; 2007 Nov; 21(11):1055-8. PubMed ID: 17724767
[TBL] [Abstract][Full Text] [Related]
9. Essential oil from Chenopodium ambrosioides and main components: activity against Leishmania, their mitochondria and other microorganisms.
Monzote L; García M; Pastor J; Gil L; Scull R; Maes L; Cos P; Gille L
Exp Parasitol; 2014 Jan; 136():20-6. PubMed ID: 24184772
[TBL] [Abstract][Full Text] [Related]
10. Leishmania amazonensis: effects of oral treatment with copaiba oil in mice.
dos Santos AO; Costa MA; Ueda-Nakamura T; Dias-Filho BP; da Veiga-Júnior VF; de Souza Lima MM; Nakamura CV
Exp Parasitol; 2011 Oct; 129(2):145-51. PubMed ID: 21771592
[TBL] [Abstract][Full Text] [Related]
11. Combinations of ascaridole, carvacrol, and caryophyllene oxide against Leishmania.
Pastor J; García M; Steinbauer S; Setzer WN; Scull R; Gille L; Monzote L
Acta Trop; 2015 May; 145():31-8. PubMed ID: 25697866
[TBL] [Abstract][Full Text] [Related]
12. In vitro antileishmanial activity and cytotoxicity of essential oil from Lippia sidoides Cham.
de Medeiros Md; da Silva AC; Citó AM; Borges AR; de Lima SG; Lopes JA; Figueiredo RC
Parasitol Int; 2011 Sep; 60(3):237-41. PubMed ID: 21421075
[TBL] [Abstract][Full Text] [Related]
13. Effect of imidocarb and levamisole on the experimental infection of BALB/c mice by Leishmania (Leishmania) amazonensis.
Rodrigues FH; Afonso-Cardoso SR; Gomes MA; Beletti ME; Rocha A; Guimarães AH; Candeloro I; de Souza MA
Vet Parasitol; 2006 Jun; 139(1-3):37-46. PubMed ID: 16647821
[TBL] [Abstract][Full Text] [Related]
14. Tamoxifen as a potential antileishmanial agent: efficacy in the treatment of Leishmania braziliensis and Leishmania chagasi infections.
Miguel DC; Zauli-Nascimento RC; Yokoyama-Yasunaka JK; Katz S; Barbiéri CL; Uliana SR
J Antimicrob Chemother; 2009 Feb; 63(2):365-8. PubMed ID: 19095684
[TBL] [Abstract][Full Text] [Related]
15. Effect of Brazilian copaiba oils on Leishmania amazonensis.
Santos AO; Ueda-Nakamura T; Dias Filho BP; Veiga Junior VF; Pinto AC; Nakamura CV
J Ethnopharmacol; 2008 Nov; 120(2):204-8. PubMed ID: 18775772
[TBL] [Abstract][Full Text] [Related]
16. In vivo activity of perifosine against Leishmania amazonensis.
Cabrera-Serra MG; Valladares B; Piñero JE
Acta Trop; 2008 Oct; 108(1):20-5. PubMed ID: 18801328
[TBL] [Abstract][Full Text] [Related]
17. Antileishmanial activity of a tetralone isolated from Ampelocera edentula, a Bolivian plant used as a treatment for cutaneous leishmaniasis.
Fournet A; Barrios AA; Muñoz V; Hocquemiller R; Roblot F; Cavé A
Planta Med; 1994 Feb; 60(1):8-12. PubMed ID: 8134421
[TBL] [Abstract][Full Text] [Related]
18. The in vivo activity of 1,3,4-thiadiazolium-2-aminide compounds in the treatment of cutaneous and visceral leishmaniasis.
Rodrigues RF; Charret KS; Campos MC; Amaral V; Echevarria A; Dos Reis C; Canto-Cavalheiro MM; Leon LL
J Antimicrob Chemother; 2012 Jan; 67(1):182-90. PubMed ID: 21987238
[TBL] [Abstract][Full Text] [Related]
19. Antileishmanial activity of the essential oil from Bixa orellana.
Monzote L; García M; Scull R; Cuellar A; Setzer WN
Phytother Res; 2014 May; 28(5):753-8. PubMed ID: 23983115
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of miltefosine treatment in Leishmania amazonensis-infected BALB/c mice.
Godinho JL; Simas-Rodrigues C; Silva R; Ürmenyi TP; de Souza W; Rodrigues JC
Int J Antimicrob Agents; 2012 Apr; 39(4):326-31. PubMed ID: 22226653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
